PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership
Phase Holographic Imaging (PHI) becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
Following productive discussions over the summer, PHI is joining two influential organizations in the field of regenerative medicine. Discussions at the World Stem Cell Summit in Winston-Salem, where PHI participated in June this year, led to the Company joining ARM. As a next step in Sweden, PHI will attend the upcoming ATMP’s 4th Annual Conference in Uppsala on December 5-6.
PHI CEO, Patrik Eschricht, adds:
“As we head into autumn, our partnership network in regenerative medicine continues to expand, and we are ready to speak further about our non-invasive technology for standard cell quality control. Our commitment to expanding our network remains strong, and our calendars are brimming with productive meetings.”
About ARM
The Alliance for Regenerative Medicine (ARM) is the global voice for engineered cell therapies and genetic medicines. Representing over 475 members across 25 countries, ARM leads on critical issues, such as regulatory pathways, market access, industrialization, stakeholder engagement, and access to capital. For more details, visit http://www.alliancerm.org.
About ATMP Sweden
ATMP Sweden is a national network focused on gene and cell therapy solutions. Through collaboration among researchers, healthcare professionals, and industry partners, ATMP Sweden aims to enhance Advanced Therapy Medicinal Products (ATMP) development, address challenges, and create innovative solutions. For more details, visit https://atmpsweden.se.
For additional information, please contact:
Lisa Bodily
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis
Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.
